@TargetCancer
@TargetCancer
Target Cancer | Precision Medicine: Why We Chose Dogs First @TargetCancer | Uploaded September 2024 | Updated October 2024, 7 hours ago.
Have you ever wondered why ImpriMed focuses on dogs for precision medicine?

Dr. Sungwon Lim from ImpriMed, Inc. explains the science and business advantages behind this decision.

Watch the full episode on YouTube: youtube.com/watch?v=SZqi9drwxmE
Precision Medicine: Why We Chose Dogs FirstBreakthrough Cancer Treatment: Alpha Radiation Therapy by Dr. Robert Den | TCP Ep.67How Everyday Exposures Increase Cancer Risk | TCP Ep. 64Unlocking the Power of Genetic Repair for Vision RestorationThe Surprising Link Between Intermittent Fasting, Diabetes, and Cancer. Dr. Fung Explains - Part 2New brain cancer treatmentsA clinical trial is your best chanceWhy some cancers are very complexEmpowering Doctors and Patients with AI for Unparalleled Cancer CareSupercharge your Cancer Treatment with Machine Learning.Beyond the Hype - promo clipThe future of curing glioblastoma

Precision Medicine: Why We Chose Dogs First @TargetCancer

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER